Four cases of Candida albicans infections with isolates developing pink colonies on CHROMagar Candida plates

Mycoses

Volumn 48, Issue 6, 2005, Pages 378-381

  Saunte, D M ^a   Klingspor, L ^b   Jalal, S ^b   Arnau, J ^c,d   Arendrup, M C ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Biotechnological Institute Denmark   (Denmark)

^d Unizyme Laboratories A/S   (Denmark)

Author keywords

Candida albicans; CHROMagar Candida plates

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA; PIGMENT; RIBOSOMAL SPACER DNA; RIBOSOME DNA; RNA 18S;

ADOLESCENT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; COLONY FORMATION; COLOR; CULTURE MEDIUM; FEMALE; FUNGAL METABOLISM; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VULVOVAGINITIS; YEAST; ADULT; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY;

CANDIDA; CANDIDA ALBICANS;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; COLOR; CULTURE MEDIA; DNA, FUNGAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PIGMENTS, BIOLOGICAL; RNA, RIBOSOMAL, 18S; SEQUENCE ANALYSIS, DNA;

EID: 33644697553     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2005.01146.x     Document Type: Article

References (20)

1. Bouchara JP, Declerck P, Cimon B, Planchenault C, de Gentile L, Chabasse D. Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations. Clin Microbiol Infect 1996 2 : 202 8.
2. Silva JO, Franceschini SA, Lavrador MA, Candido RC. Performance of selective and differential media in the primary isolation of yeasts from different biological samples. Mycopathologia 2004 157 : 29 36.
3. Willinger B, Hillowoth C, Selitsch B, Manafi M. Performance of candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol 2001 39 : 3793 5.
4. Bernal S, Martin ME, Garcia M, Aller AI, Martinez MA, Gutierrez MJ. Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis 1996 24 : 201 4.
5. Powell HL, Sand CA, Rennie RP. Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species. Diagn Microbiol Infect Dis 1998 32 : 201 4.
6. Baumgartner C, Freydiere AM, Gille Y. Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J Clin Microbiol 1996 34 : 454 6.
7. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994 32 : 1923 9.
8. Pfaller MA, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol 1996 34 : 58 61.
9. Willinger B, Manafi M. Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses 1999 42 : 61 65.
10. Yucesoy M, Marol S. Performance of CHROMAGAR candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob 2003 2 : 8.
11. Odds FC, Davidson A. ''Room temperature" use of CHROMagar Candida. Diagn Microbiol Infect Dis 2000 38 : 147 50.
12. Knepp JH, Geahr MA, Forman MS, Valsamakis A. Comparison of automated and manual nucleic acid extraction methods for detection of enterovirus RNA. J Clin Microbiol 2003 41 : 3532 6.
13. Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2000 44 : 710 2.
14. Jonasson J, Olofsson M, Monstein HJ. Classification, identification and subtyping of bacteria based on pyrosequencing and signature matching of 16S rDNA fragments. APMIS 2002 110 : 263 72.
15. Gharizadeh B, Norberg E, Loffler J et al. Identification of medically important fungi by the Pyrosequencing technology. Mycoses 2004 : 47 : 29 33.
16. Koehler AP, Chu KC, Houang ET, Cheng AF. Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol 1999 37 : 422 6.
17. Tintelnot K, Haase G, Seibold M et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000 38 : 1599 608.
18. Jabra-Rizk MA, Falkler WA Jr., Merz WG, Baqui AA, Kelley JI, Meiller TF. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol 2000 38 : 2423 6.
19. Polacheck I, Strahilevitz J, Sullivan D, Donnelly S, Salkin IF, Coleman DC. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol 2000 38 : 170 4.
20. Freydiere AM. Evaluation of CHROMagar Candida plates. J Clin Microbiol 1996 34 : 2048.